Hydromorphone inactive ingredients by manufacturer
Wondering whether your Hydromorphone has lactose, gluten, soy, a dye or gelatin in it? The medicine is the same, but the fillers, coatings and colors differ from one company to the next. This page shows what each Hydromorphone product's FDA label lists, so you can find a version that leaves out what you avoid and ask your pharmacist for it by its NDC.
We have read the FDA labels of 62 of the 72 current Hydromorphone products on the market today, from 17 companies listing it with the FDA, and lined them up side by side. 9 are still being read and will appear on a later visit. 1 could not be linked to a current label.
Ask about your bottle
Is there something in your Hydromorphone? Ask in plain words.
Name the company, strength or the NDC on your bottle and the ingredient you avoid. The answer comes only from the FDA labels on this page.
Answers are drawn from the FDA label data on this page and checked against it. They are not medical advice: confirm with your pharmacist before relying on them.
The short answer
Which Hydromorphone products list lactose, a gluten source, soy, dyes or gelatin?
-
LactoseDiffers by manufacturer
26 of 62 checked products list lactose; 36 do not. See the products
-
Wheat or gluten sourceNo checked product
No checked Hydromorphone product lists a wheat or gluten source.
-
SoyNo checked product
No checked Hydromorphone product lists soy.
-
Synthetic dyesDiffers by manufacturer
16 of 62 checked products list synthetic dyes; 46 do not. See the products
-
GelatinNo checked product
No checked Hydromorphone product lists gelatin.
Also listed by some products: Sulfites 18 of 62 Titanium dioxide 13 of 62 Carmine or shellac 2 of 62 Propylene glycol 5 of 62 PEG or polysorbate 13 of 62 Sorbitol or mannitol 3 of 62 Sugar 4 of 62
Find a version without it
Every current Hydromorphone product and what its label lists
| Product | Lists | Inactive ingredients on the label |
|---|---|---|
| American Health Packaging 3 products | ||
| 5 mg/5 mL oral solutionNDC 60687-0566-86 | Sulfites Sugar (sucrose, dextrose) |
Show 6 ingredientsGLYCERIN, METHYLPARABEN, PROPYLPARABEN, SODIUM METABISULFITE, SUCROSE, WATER |
| 2 mg tabletNDC 60687-0579-01 | Lactose |
Show 4 ingredientsLACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, STEARIC ACID |
| 4 mg tabletNDC 60687-0590-01 | Still being read | Not read yet |
| Ascent Pharmaceuticals Inc 4 products | ||
| 5 mg/5 mL oral solutionNDC 43602-0001-47 | Sulfites Sugar (sucrose, dextrose) |
Show 6 ingredientsGLYCERIN, METHYLPARABEN, PROPYLPARABEN, SODIUM METABISULFITE, SUCROSE, WATER |
| 2 mg tabletNDC 43602-0002-05 | Lactose Sulfites Synthetic dyes |
Show 6 ingredientsANHYDROUS LACTOSE, CELLULOSE, MICROCRYSTALLINE, D&C RED NO. 30, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| 4 mg tabletNDC 43602-0003-05 | Still being read | Not read yet |
| 8 mg tabletNDC 43602-0004-05 | Lactose Sulfites |
Show 4 ingredientsANHYDROUS LACTOSE, CELLULOSE, MICROCRYSTALLINE, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| Asclemed Usa Inc. 3 products | ||
| 2 mg tabletNDC 87063-0037-01 | Lactose Sulfites Synthetic dyes |
Show 5 ingredientsANHYDROUS LACTOSE, D&C RED NO. 30, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| 4 mg tabletNDC 87063-0038-01 | Lactose Sulfites Synthetic dyes |
Show 4 ingredientsANHYDROUS LACTOSE, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| 8 mg tabletNDC 87063-0039-01 | Lactose Sulfites |
Show 3 ingredientsANHYDROUS LACTOSE, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| Aurolife Pharma, LLC 3 products | ||
| 2 mg tabletNDC 13107-0107-01 | Lactose Synthetic dyes |
Show 7 ingredientsANHYDROUS LACTOSE, CELLULOSE, MICROCRYSTALLINE, D&C RED NO. 30, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO |
| 4 mg tabletNDC 13107-0108-01 | Lactose Synthetic dyes |
Show 6 ingredientsANHYDROUS LACTOSE, CELLULOSE, MICROCRYSTALLINE, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO |
| 8 mg tabletNDC 13107-0109-01 | Lactose |
Show 5 ingredientsANHYDROUS LACTOSE, CELLULOSE, MICROCRYSTALLINE, MAGNESIUM STEARATE, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO |
| Bryant Ranch Prepack 4 products | ||
| 3 mg rectal suppositoryNDC 63629-2532-01 | None of these listed |
Show 2 ingredientsCOCOA BUTTER, SILICON DIOXIDE |
| 2 mg tabletNDC 63629-4284-01 | Lactose Sulfites Synthetic dyes |
Show 5 ingredientsANHYDROUS LACTOSE, D&C RED NO. 30, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| 4 mg tabletNDC 71335-9701-00 | Lactose Sulfites Synthetic dyes |
Show 4 ingredientsANHYDROUS LACTOSE, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| 4 mg tabletNDC 71335-0723-00 | Lactose Synthetic dyes |
Show 6 ingredientsANHYDROUS LACTOSE, D&C YELLOW NO. 10, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, SILICON DIOXIDE, SODIUM STARCH GLYCOLATE TYPE A POTATO |
| Camber Pharmaceuticals, Inc. 4 products | ||
| 8 mg extended-release tabletNDC 31722-0119-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsACETONE, BUTYLATED HYDROXYTOLUENE, CELLULOSE ACETATE, FERRIC OXIDE YELLOW, HYPROMELLOSE, UNSPECIFIED, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, POLYSORBATE 80, POVIDONE, SODIUM CHLORIDE, TITANIUM DIOXIDE |
| 12 mg extended-release tabletNDC 31722-0120-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsACETONE, BUTYLATED HYDROXYTOLUENE, CELLULOSE ACETATE, FERRIC OXIDE YELLOW, HYPROMELLOSE, UNSPECIFIED, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, POLYSORBATE 80, POVIDONE, SODIUM CHLORIDE, TITANIUM DIOXIDE |
| 16 mg extended-release tabletNDC 31722-0121-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsACETONE, BUTYLATED HYDROXYTOLUENE, CELLULOSE ACETATE, FERRIC OXIDE YELLOW, HYPROMELLOSE, UNSPECIFIED, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, POLYSORBATE 80, POVIDONE, SODIUM CHLORIDE, TITANIUM DIOXIDE |
| 32 mg extended-release tabletNDC 31722-0122-01 | Titanium dioxide Propylene glycol Polyethylene glycol or polysorbate |
Show 15 ingredientsACETONE, BUTYLATED HYDROXYTOLUENE, CELLULOSE ACETATE, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, HYPROMELLOSE, UNSPECIFIED, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, POVIDONE, PROPYLENE GLYCOL, SODIUM CHLORIDE, TALC, TITANIUM DIOXIDE |
| Fresenius Kabi USA, LLC 7 products | ||
| 0.2 mg/mL injectionNDC 76045-0121-11 | Still being read | Not read yet |
| 1 mg/mL injectionNDC 76045-0009-05 | None of these listed |
Show 3 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, WATER |
| 1 mg/mL injectionNDC 63323-0852-25 | Still being read | Not read yet |
| 2 mg/mL injectionNDC 63323-0853-25 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM |
| 2 mg/mL injectionNDC 76045-0010-10 | Still being read | Not read yet |
| 4 mg/mL injectionNDC 63323-0854-10 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM |
| 10 mg/mL injectionNDC 63323-0851-10 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM |
| Hikma Pharmaceuticals USA Inc. 8 products | ||
| 0.2 mg/mL injectionNDC 00641-6259-10 | None of these listed |
Show 3 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, WATER |
| 0.5 mg/0.5 mL injectionNDC 00641-6206-10 | None of these listed |
Show 3 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, WATER |
| 1 mg/mL injectionNDC 00641-6169-10 | None of these listed |
Show 3 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, WATER |
| 2 mg/mL injectionNDC 00641-2341-41 | None of these listed |
Show 6 ingredientsEDETATE DISODIUM, HYDROCHLORIC ACID, METHYLPARABEN, PROPYLPARABEN, SODIUM HYDROXIDE, WATER |
| 2 mg/mL injectionNDC 00641-6151-25 | None of these listed |
Show 3 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, WATER |
| 2 mg/mL injectionNDC 00641-6170-10 | None of these listed |
Show 3 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, WATER |
| 2 mg/mL injectionNDC 00641-6254-01 | Still being read | Not read yet |
| 1 mg/mL oral solutionNDC 00054-0386-63 | Synthetic dyes Propylene glycol Sorbitol or mannitol |
Show 8 ingredientsFD&C RED NO. 40, METHYLPARABEN, PROPYLENE GLYCOL, PROPYLPARABEN, RASPBERRY, SACCHARIN SODIUM ANHYDROUS, SORBITOL, WATER |
| Hospira, Inc. 7 products | ||
| 0.5 mg/0.5 mL injectionNDC 00409-4264-01 | None of these listed |
Show 4 ingredientsLACTIC ACID, UNSPECIFIED FORM, SODIUM CHLORIDE, SODIUM HYDROXIDE, SODIUM LACTATE |
| 0.25 mg/0.5 mL injectionNDC 00409-1805-01 | None of these listed |
Show 4 ingredientsLACTIC ACID, UNSPECIFIED FORM, SODIUM CHLORIDE, SODIUM HYDROXIDE, SODIUM LACTATE |
| 1 mg/mL injectionNDC 00409-1283-05 | No current label | Not available |
| 2 mg/mL injectionNDC 00409-1312-30 | None of these listed |
Show 4 ingredientsLACTIC ACID, UNSPECIFIED FORM, SODIUM CHLORIDE, SODIUM HYDROXIDE, SODIUM LACTATE |
| 2 mg/mL injectionNDC 00409-3365-10 | None of these listed |
Show 4 ingredientsLACTIC ACID, UNSPECIFIED FORM, SODIUM CHLORIDE, SODIUM HYDROXIDE, SODIUM LACTATE |
| 4 mg/mL injectionNDC 00409-1304-31 | None of these listed |
Show 4 ingredientsLACTIC ACID, UNSPECIFIED FORM, SODIUM CHLORIDE, SODIUM HYDROXIDE, SODIUM LACTATE |
| 10 mg/mL injectionNDC 00409-2634-01 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM |
| Padagis US LLC 5 products | ||
| 8 mg extended-release tabletNDC 00574-0293-01 | Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate Sorbitol or mannitol |
Show 18 ingredientsAMMONIO METHACRYLATE COPOLYMER TYPE A, ETHYLCELLULOSE (100 MPA.S), FERRIC OXIDE RED, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, HYPROMELLOSE 2910 (3 MPA.S), HYPROMELLOSE 2910 (6 MPA.S), MAGNESIUM STEARATE, MANNITOL, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 400, POVIDONE K30, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 12 mg extended-release tabletNDC 00574-0294-01 | Titanium dioxide Carmine or shellac Propylene glycol Polyethylene glycol or polysorbate Sorbitol or mannitol |
Show 17 ingredientsAMMONIO METHACRYLATE COPOLYMER TYPE A, ETHYLCELLULOSE (100 MPA.S), FERROSOFERRIC OXIDE, HYPROMELLOSE 2910 (3 MPA.S), HYPROMELLOSE 2910 (6 MPA.S), MAGNESIUM STEARATE, MANNITOL, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 400, POLYSORBATE 80, POVIDONE K30, PROPYLENE GLYCOL, SHELLAC, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE, TRIETHYL CITRATE |
| 16 mg extended-release tabletNDC 00574-0295-01 | Still being read | Not read yet |
| 32 mg extended-release tabletNDC 00574-0297-01 | Still being read | Not read yet |
| 3 mg rectal suppositoryNDC 00574-7224-06 | None of these listed |
Show 2 ingredientsCOCOA BUTTER, SILICON DIOXIDE |
| Redpharm Drug 1 product | ||
| 2 mg tabletNDC 67296-1414-01 | Lactose |
Show 4 ingredientsLACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, STEARIC ACID |
| Rhodes Pharmaceuticals LLC 8 products | ||
| 5 mg/5 mL oral solutionNDC 42858-0304-16 | Sulfites Sugar (sucrose, dextrose) |
Show 6 ingredientsGLYCERIN, METHYLPARABEN, PROPYLPARABEN, SODIUM METABISULFITE, SUCROSE, WATER |
| 5 mg/5 mL oral solutionNDC 42858-0416-16 | Sulfites Sugar (sucrose, dextrose) |
Show 6 ingredientsGlycerin, Methylparaben, Propylparaben, Sodium metabisulfite, Sucrose, Water |
| 2 mg tabletNDC 42858-0122-01 | Lactose Sulfites Synthetic dyes |
Show 5 ingredientsAnhydrous Lactose, D&C Red No. 30, D&C Yellow No. 10, Magnesium Stearate, Sodium metabisulfite |
| 2 mg tabletNDC 42858-0301-01 | Lactose Sulfites Synthetic dyes |
Show 5 ingredientsANHYDROUS LACTOSE, D&C RED NO. 30, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| 4 mg tabletNDC 42858-0234-01 | Lactose Sulfites Synthetic dyes |
Show 4 ingredientsAnhydrous Lactose, D&C Yellow No. 10, Magnesium Stearate, Sodium metabisulfite |
| 4 mg tabletNDC 42858-0302-01 | Lactose Sulfites Synthetic dyes |
Show 4 ingredientsANHYDROUS LACTOSE, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| 8 mg tabletNDC 42858-0303-01 | Lactose Sulfites |
Show 3 ingredientsANHYDROUS LACTOSE, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| 8 mg tabletNDC 42858-0338-01 | Lactose Sulfites |
Show 3 ingredientsAnhydrous Lactose, Magnesium Stearate, Sodium metabisulfite |
| SpecGx LLC 3 products | ||
| 2 mg tabletNDC 00406-3243-01 | Lactose |
Show 4 ingredientsLACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, STEARIC ACID |
| 4 mg tabletNDC 00406-3244-01 | Lactose |
Show 4 ingredientsLACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, STEARIC ACID |
| 8 mg tabletNDC 00406-3249-01 | Lactose |
Show 4 ingredientsLACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, STEARIC ACID |
| St. Mary's Medical Park Pharmacy 1 product | ||
| 4 mg tabletNDC 60760-0998-60 | Lactose Sulfites Synthetic dyes |
Show 4 ingredientsANHYDROUS LACTOSE, D&C YELLOW NO. 10, MAGNESIUM STEARATE, SODIUM METABISULFITE |
| Teva Parenteral Medicines, Inc. 3 products | ||
| 10 mg/mL injectionNDC 00703-0018-01 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM |
| 10 mg/mL injectionNDC 00703-0110-03 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM |
| 10 mg/mL injectionNDC 00703-0113-03 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM |
| Trigen Laboratories, LLC 4 products | ||
| 8 mg extended-release tabletNDC 13811-0701-10 | Lactose Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 14 ingredientsCELLULOSE ACETATE, FD&C RED NO. 40 ALUMINUM LAKE, FERROSOFERRIC OXIDE, HYPROMELLOSE 2208 (100 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 7000000, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, SILICON DIOXIDE, SODIUM CHLORIDE, TITANIUM DIOXIDE, TRIACETIN |
| 12 mg extended-release tabletNDC 13811-0702-10 | Lactose Titanium dioxide Polyethylene glycol or polysorbate |
Show 14 ingredientsCELLULOSE ACETATE, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, HYPROMELLOSE 2208 (100 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 7000000, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, SILICON DIOXIDE, SODIUM CHLORIDE, TITANIUM DIOXIDE, TRIACETIN |
| 16 mg extended-release tabletNDC 13811-0703-10 | Lactose Synthetic dyes Titanium dioxide Polyethylene glycol or polysorbate |
Show 16 ingredientsCELLULOSE ACETATE, D&C YELLOW NO. 10 ALUMINUM LAKE, FD&C YELLOW NO. 6 ALUMINUM LAKE, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, HYPROMELLOSE 2208 (100 MPA.S), HYPROMELLOSE 2910 (5 MPA.S), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 7000000, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, SILICON DIOXIDE, SODIUM CHLORIDE, TITANIUM DIOXIDE, TRIACETIN |
| 32 mg extended-release tabletNDC 13811-0704-10 | Still being read | Not read yet |
| XLCare Pharmaceuticals, Inc. 4 products | ||
| 8 mg extended-release tabletNDC 72865-0168-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsACETONE, BUTYLATED HYDROXYTOLUENE, CELLULOSE ACETATE, FERRIC OXIDE YELLOW, HYPROMELLOSE, UNSPECIFIED, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, POLYSORBATE 80, POVIDONE, SODIUM CHLORIDE, TITANIUM DIOXIDE |
| 12 mg extended-release tabletNDC 72865-0169-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsACETONE, BUTYLATED HYDROXYTOLUENE, CELLULOSE ACETATE, FERRIC OXIDE YELLOW, HYPROMELLOSE, UNSPECIFIED, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, POLYSORBATE 80, POVIDONE, SODIUM CHLORIDE, TITANIUM DIOXIDE |
| 16 mg extended-release tabletNDC 72865-0170-01 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 13 ingredientsACETONE, BUTYLATED HYDROXYTOLUENE, CELLULOSE ACETATE, FERRIC OXIDE YELLOW, HYPROMELLOSE, UNSPECIFIED, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, POLYSORBATE 80, POVIDONE, SODIUM CHLORIDE, TITANIUM DIOXIDE |
| 32 mg extended-release tabletNDC 72865-0171-01 | Titanium dioxide Propylene glycol Polyethylene glycol or polysorbate |
Show 15 ingredientsACETONE, BUTYLATED HYDROXYTOLUENE, CELLULOSE ACETATE, FERRIC OXIDE YELLOW, FERROSOFERRIC OXIDE, HYPROMELLOSE, UNSPECIFIED, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, POLYETHYLENE OXIDE 200000, POVIDONE, PROPYLENE GLYCOL, SODIUM CHLORIDE, TALC, TITANIUM DIOXIDE |
A product with none of these listed is not certified to be without them: the label says what the manufacturer declared, and the source of a starch or a flavor is often not stated. The companies are the FDA's labelers, which include repackagers and distributors selling another company's product under their own label. The NDC opens the product's own page, with the full label and its inactive-ingredient notes.
Hydromorphone without lactose
Lactose: milk sugar; a concern with lactose intolerance or a milk allergy. 26 of 62 checked products list lactose; 36 do not.
Does not list lactose
- American Health Packaging: 5 mg/5 mL oral solution
- Ascent: 5 mg/5 mL oral solution
- Bryant Ranch Prepack: 3 mg rectal suppository
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10), 1 mg/mL oral solution
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 8 mg extended-release tablet, 12 mg extended-release tablet, 3 mg rectal suppository
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16)
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
Lists lactose
- American Health Packaging: 2 mg tablet
- Ascent: 2 mg tablet, 8 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 2 mg tablet, 4 mg tablet (NDC 71335-9701-00), 4 mg tablet (NDC 71335-0723-00)
- Redpharm Drug: 2 mg tablet
- Rhodes: 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- St. Mary's Medical Park Pharmacy: 4 mg tablet
- Trigen: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
Hydromorphone without synthetic dyes
Synthetic dyes: FD&C or D&C colorants and their aluminum lakes. 16 of 62 checked products list synthetic dyes; 46 do not.
Does not list synthetic dyes
- American Health Packaging: 5 mg/5 mL oral solution, 2 mg tablet
- Ascent: 5 mg/5 mL oral solution, 8 mg tablet
- Asclemed: 8 mg tablet
- Aurolife: 8 mg tablet
- Bryant Ranch Prepack: 3 mg rectal suppository
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10)
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 8 mg extended-release tablet, 12 mg extended-release tablet, 3 mg rectal suppository
- Redpharm Drug: 2 mg tablet
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
- Trigen: 12 mg extended-release tablet
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
Lists synthetic dyes
- Ascent: 2 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet
- Bryant Ranch Prepack: 2 mg tablet, 4 mg tablet (NDC 71335-9701-00), 4 mg tablet (NDC 71335-0723-00)
- Hikma: 1 mg/mL oral solution
- Rhodes: 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01)
- St. Mary's Medical Park Pharmacy: 4 mg tablet
- Trigen: 8 mg extended-release tablet, 16 mg extended-release tablet
Hydromorphone without sulfites
Sulfites: metabisulfite or bisulfite preservatives; a concern with sulfite sensitivity or asthma. 18 of 62 checked products list sulfites; 44 do not.
Does not list sulfites
- American Health Packaging: 2 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 3 mg rectal suppository, 4 mg tablet
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10), 1 mg/mL oral solution
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 8 mg extended-release tablet, 12 mg extended-release tablet, 3 mg rectal suppository
- Redpharm Drug: 2 mg tablet
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
- Trigen: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
Lists sulfites
- American Health Packaging: 5 mg/5 mL oral solution
- Ascent: 5 mg/5 mL oral solution, 2 mg tablet, 8 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 2 mg tablet, 4 mg tablet
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16), 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- St. Mary's Medical Park Pharmacy: 4 mg tablet
Hydromorphone without titanium dioxide
Titanium dioxide: A white colorant some people choose to avoid. 13 of 62 checked products list titanium dioxide; 49 do not.
Does not list titanium dioxide
- American Health Packaging: 5 mg/5 mL oral solution, 2 mg tablet
- Ascent: 5 mg/5 mL oral solution, 2 mg tablet, 8 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 3 mg rectal suppository, 2 mg tablet, 4 mg tablet (NDC 71335-9701-00), 4 mg tablet (NDC 71335-0723-00)
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10), 1 mg/mL oral solution
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 3 mg rectal suppository
- Redpharm Drug: 2 mg tablet
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16), 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- St. Mary's Medical Park Pharmacy: 4 mg tablet
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
Lists titanium dioxide
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
- Padagis: 8 mg extended-release tablet, 12 mg extended-release tablet
- Trigen: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
Hydromorphone without carmine or shellac
Carmine or shellac: insect-derived red colorant or coating glaze. 2 of 62 checked products list carmine or shellac; 60 do not.
Does not list carmine or shellac
- American Health Packaging: 5 mg/5 mL oral solution, 2 mg tablet
- Ascent: 5 mg/5 mL oral solution, 2 mg tablet, 8 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 3 mg rectal suppository, 2 mg tablet, 4 mg tablet (NDC 71335-9701-00), 4 mg tablet (NDC 71335-0723-00)
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10), 1 mg/mL oral solution
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 3 mg rectal suppository
- Redpharm Drug: 2 mg tablet
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16), 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- St. Mary's Medical Park Pharmacy: 4 mg tablet
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
- Trigen: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
Lists carmine or shellac
Hydromorphone without propylene glycol
Propylene glycol: A solvent in liquids and capsules; a concern in kidney disease, for infants, and at high doses. 5 of 62 checked products list propylene glycol; 57 do not.
Does not list propylene glycol
- American Health Packaging: 5 mg/5 mL oral solution, 2 mg tablet
- Ascent: 5 mg/5 mL oral solution, 2 mg tablet, 8 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 3 mg rectal suppository, 2 mg tablet, 4 mg tablet (NDC 71335-9701-00), 4 mg tablet (NDC 71335-0723-00)
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10)
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 3 mg rectal suppository
- Redpharm Drug: 2 mg tablet
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16), 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- St. Mary's Medical Park Pharmacy: 4 mg tablet
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
- Trigen: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
Lists propylene glycol
- Camber: 32 mg extended-release tablet
- Hikma: 1 mg/mL oral solution
- Padagis: 8 mg extended-release tablet, 12 mg extended-release tablet
- XLCare: 32 mg extended-release tablet
Hydromorphone without polyethylene glycol or polysorbate
Polyethylene glycol or polysorbate: PEG, macrogol or polysorbate; a rare cause of allergic reactions. 13 of 62 checked products list polyethylene glycol or polysorbate; 49 do not.
Does not list polyethylene glycol or polysorbate
- American Health Packaging: 5 mg/5 mL oral solution, 2 mg tablet
- Ascent: 5 mg/5 mL oral solution, 2 mg tablet, 8 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 3 mg rectal suppository, 2 mg tablet, 4 mg tablet (NDC 71335-9701-00), 4 mg tablet (NDC 71335-0723-00)
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10), 1 mg/mL oral solution
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 3 mg rectal suppository
- Redpharm Drug: 2 mg tablet
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16), 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- St. Mary's Medical Park Pharmacy: 4 mg tablet
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
Lists polyethylene glycol or polysorbate
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
- Padagis: 8 mg extended-release tablet, 12 mg extended-release tablet
- Trigen: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
Hydromorphone without sorbitol or mannitol
Sorbitol or mannitol: sugar alcohols that can cause bloating or diarrhea in larger amounts. 3 of 62 checked products list sorbitol or mannitol; 59 do not.
Does not list sorbitol or mannitol
- American Health Packaging: 5 mg/5 mL oral solution, 2 mg tablet
- Ascent: 5 mg/5 mL oral solution, 2 mg tablet, 8 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 3 mg rectal suppository, 2 mg tablet, 4 mg tablet (NDC 71335-9701-00), 4 mg tablet (NDC 71335-0723-00)
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10)
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 3 mg rectal suppository
- Redpharm Drug: 2 mg tablet
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16), 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- St. Mary's Medical Park Pharmacy: 4 mg tablet
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
- Trigen: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
Lists sorbitol or mannitol
Hydromorphone without sugar (sucrose or dextrose)
Sugar (sucrose, dextrose): A consideration in diabetes, mostly in liquids and chewables. 4 of 62 checked products list sugar (sucrose or dextrose); 58 do not.
Does not list sugar (sucrose or dextrose)
- American Health Packaging: 2 mg tablet
- Ascent: 2 mg tablet, 8 mg tablet
- Asclemed: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Aurolife: 2 mg tablet, 4 mg tablet, 8 mg tablet
- Bryant Ranch Prepack: 3 mg rectal suppository, 2 mg tablet, 4 mg tablet (NDC 71335-9701-00), 4 mg tablet (NDC 71335-0723-00)
- Camber: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
- Fresenius Kabi: 1 mg/mL injection, 2 mg/mL injection, 4 mg/mL injection, 10 mg/mL injection
- Hikma: 0.2 mg/mL injection, 0.5 mg/0.5 mL injection, 1 mg/mL injection, 2 mg/mL injection (NDC 00641-2341-41), 2 mg/mL injection (NDC 00641-6151-25), 2 mg/mL injection (NDC 00641-6170-10), 1 mg/mL oral solution
- Hospira: 0.5 mg/0.5 mL injection, 0.25 mg/0.5 mL injection, 2 mg/mL injection (NDC 00409-1312-30), 2 mg/mL injection (NDC 00409-3365-10), 4 mg/mL injection, 10 mg/mL injection
- Padagis: 8 mg extended-release tablet, 12 mg extended-release tablet, 3 mg rectal suppository
- Redpharm Drug: 2 mg tablet
- Rhodes: 2 mg tablet (NDC 42858-0122-01), 2 mg tablet (NDC 42858-0301-01), 4 mg tablet (NDC 42858-0234-01), 4 mg tablet (NDC 42858-0302-01), 8 mg tablet (NDC 42858-0303-01), 8 mg tablet (NDC 42858-0338-01)
- SpecGx: 2 mg tablet, 4 mg tablet, 8 mg tablet
- St. Mary's Medical Park Pharmacy: 4 mg tablet
- Teva Parenteral Medicines: 10 mg/mL injection (NDC 00703-0018-01), 10 mg/mL injection (NDC 00703-0110-03), 10 mg/mL injection (NDC 00703-0113-03)
- Trigen: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet
- XLCare: 8 mg extended-release tablet, 12 mg extended-release tablet, 16 mg extended-release tablet, 32 mg extended-release tablet
Lists sugar (sucrose or dextrose)
- American Health Packaging: 5 mg/5 mL oral solution
- Ascent: 5 mg/5 mL oral solution
- Rhodes: 5 mg/5 mL oral solution (NDC 42858-0304-16), 5 mg/5 mL oral solution (NDC 42858-0416-16)
At the pharmacy counter
How to use this at the pharmacy counter
- Pick the company whose list suits you and copy the NDC from the table. Many pharmacies order from wholesalers that carry several companies' versions and can request a particular one if you ask before the prescription is filled; some buy from one contracted source only, and a few insurance plans cover only certain NDCs, so ask the pharmacist to check.
- Treat "does not list" as exactly that. The label is what the manufacturer declared; a flavor or a starch may have an unstated source, and lines change. For celiac disease or a serious allergy, ask the manufacturer's medical information line for a written statement about the lot you have.
- Check the bottle each refill. A different company usually means a different shape, color and inactive-ingredient list; the pharmacist can tell you who made it, and the two-NDC comparison shows the difference line by line.
- If you need one company's version kept constant, ask your prescriber to write that company or the NDC on the prescription and tell the pharmacy you need it held. Rules vary by state and plan, so confirm with the pharmacist.
Common questions about Hydromorphone inactive ingredients
Is Hydromorphone gluten-free?
Does Hydromorphone contain lactose?
Does Hydromorphone contain soy?
Is there a dye-free Hydromorphone?
Does Hydromorphone contain gelatin?
Why do the inactive ingredients differ between manufacturers?
Can my pharmacy give me a specific manufacturer's version?
How current is this list?
Sources: the products are the finished Hydromorphone products in the FDA's current NDC directory (openFDA), as of October 5, 2026; each inactive-ingredient list is the manufacturer's FDA Structured Product Label via DailyMed, as our label sync last read it. The concern groups are HelloPharmacist's classification of the names the label declares. Educational information only, not medical advice; confirm with your pharmacist before relying on a list. ← Back to the Hydromorphone guide